Form 990 for tax year 2024

Totals

Total revenue

$18,281,444

Total expenses

$20,311,953

Contributions and grants received

$3,492,285

Grants paid

$1,322,897

Program service revenue

$11,990,006

Investment income

$875,677

Other revenue

$1,923,476

Total assets, end of year

$35,063,665

Total liabilities, end of year

$6,901,088

Net assets or fund balances, end of year

$28,162,577

Program services expenses (Part IX)

$17,813,951

Management and general expenses

$2,478,659

Fundraising expenses

$19,343

Program service expenses (Part III)

$17,813,951

Program services were 87.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• MEETINGS AND EDUCATION, INCLUDING THE LIVER MEETING: AASLD'S DYNAMIC EDUCATIONAL PROGRAMS PROVIDE HEALTHCARE PROFESSIONALS CUTTING-EDGE ADVANCEMENTS IN SCIENCE AND INNOVATIVE NEW TECHNIQUES TO ADVANCE HEPATOLOGY TRAINING AND PROFESSIONAL DEVELOPMENT THROUGH IMMERSIVE FACE-TO-FACE EVENTS AND ROBUST ONLINE LEARNING PLATFORMS. THESE INITIATIVES FOSTER THE EXCHANGE OF GROUNDBREAKING RESEARCH, ELEVATE PATIENT CARE, AND SPARK NEW DISCOVERIES IN LIVER DISEASE MANAGEMENT. THE LIVER MEETING, AASLD'S PREMIER ANNUAL EVENT, IS A GLOBAL CORNERSTONE FOR THE FIELD OF HEPATOLOGY, SHOWCASING TRANSFORMATIVE RESEARCH AND TREATMENT OUTCOMES. ATTENDEES ENGAGE IN PLENARY AND PARALLEL SESSIONS, POSTER PRESENTATIONS, STATE-OF-THE-ART LECTURES, MEET-THE-EXPERT SESSIONS, SPECIALTY COURSES, AND SPECIAL INTEREST GROUP PROGRAMMING FOSTERING COLLABORATION AND KNOWLEDGE-SHARING AMONG LEADING EXPERTS AND PRACTITIONERS. ADDITIONALLY, AASLD HOSTS FOCUSED STAND-ALONE EVENTS LIKE THE EMERGING TOPIC CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND PARTNERS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES, AND NONPROFIT ORGANIZATIONS TO DELIVER IMPACTFUL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING ECOSYSTEM, ANCHORED BY LIVERLEARNING, THE OFFICIAL E-LEARNING PORTAL, OFFERS ON-DEMAND WEBINARS ORGANIZED BY SPECIAL INTEREST GROUPS, PROVIDING IN-DEPTH EXPLORATION OF SPECIALIZED TOPICS. LIVERLEARNING SERVES AS A COMPREHENSIVE DIGITAL REPOSITORY, HOUSING CONTENT FROM AASLD MEETINGS, PRACTICE GUIDELINES, SLIDE COMPILATIONS, AND COURSE HANDOUTS, ENABLING HEALTHCARE PROVIDERS TO SEAMLESSLY APPLY THE LATEST MEDICAL KNOWLEDGE TO CLINICAL PRACTICE. THE ORGANIZATION ALSO SUPPORTS ONLINE CONTENT THROUGH SIGNAL PLATFORM SPECIFICALLY DESIGNED FOR OUR SPECIAL INTEREST GROUPS. AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO PROVIDE AMA PRA CATEGORY 1 CREDITS FOR PHYSICIANS. ADDITIONALLY, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS, AWARDED UPON SUCCESSFUL COMPLETION OF DESIGNATED CME PROGRAMS, WITH MOC ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS.

  Expenses $9,743,304 · Grants $4,500 · Revenue $8,794,501

• PUBLICATIONS: AASLD'S JOURNALS, HEPATOLOGY, LIVER TRANSPLANTATION, AND HEPATOLOGY COMMUNICATIONS DELIVER PEER-REVIEWED, HIGH-IMPACT RESEARCH ON LIVER AND BILIARY TRACT DISEASES, SETTING THE STANDARD FOR SCIENTIFIC EXCELLENCE IN THE FIELD. AASLD'S FLAGSHIP JOURNAL, HEPATOLOGY, PUBLISHES ORIGINAL, PEER-REVIEWED ARTICLES CONCERNING ALL ASPECTS OF LIVER STRUCTURE, FUNCTION AND DISEASE. EACH MONTH, THE DISTINGUISHED EDITORIAL BOARD MONITORS AND SELECTS ONLY THE BEST ARTICLES ON SUBJECTS SUCH AS IMMUNOLOGY, CHRONIC HEPATITIS, VIRAL HEPATITIS, CIRRHOSIS, GENETIC AND METABOLIC LIVER DISEASES AND THEIR COMPLICATIONS, LIVER CANCER, AND DRUG METABOLISM. LIVER TRANSPLANTATION PUBLISHES CUTTING EDGE SCIENTIFIC BREAKTRLIVER TRANSPLANTATION, A SPECIALIZED JOURNAL, PROVIDES AUTHORITATIVE INSIGHTS INTO THE LATEST ADVANCEMENTS IN LIVER TRANSPLANTATION. HEPATOLOGY COMMUNICATIONS, AN OPEN-ACCESS, PEER-REVIEWED JOURNAL, ENSURES RAPID DISSEMINATION OF HIGH-QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH, AMPLIFYING AASLD'S COMMITMENT TO ADVANCING HEPATOLOGY WORLDWIDE.PROFESSIONAL RELATIONS: AASLD'S PROFESSIONAL RELATIONS INITIATIVES STRENGTHEN THE HEPATOLOGY COMMUNITY THROUGH:1. AASLD PRACTICE GUIDELINES: EVIDENCE-BASED RECOMMENDATIONS GROUNDED IN RIGOROUS SCIENTIFIC RESEARCH TO GUIDE PRACTITIONERS AND PATIENTS IN MAKING INFORMED HEALTHCARE DECISIONS FOR SPECIFIC CLINICAL SCENARIOS.2. PRACTICE METRICS COMMITTEE: THIS COMMITTEE DEVELOPS AND REFINES PERFORMANCE MEASURES TO EVALUATE AND ENHANCE THE QUALITY OF CARE FOR LIVER DISEASE PATIENTS FROM BOTH PROVIDER AND PATIENT PERSPECTIVES. IT DRIVES QUALITY IMPROVEMENT INITIATIVES, SUCH AS THE CIRRHOSIS QUALITY COLLABORATIVE (CQC), AND COLLABORATES WITH OTHER AASLD COMMITTEES AND SPECIALTY SOCIETIES TO ADVANCE PATIENT SAFETY AND CARE STANDARDS.3. RELATED SOCIETY COLLABORATIONS: AASLD FOSTERS PARTNERSHIPS WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES TO ADVANCE HEPATOLOGY THROUGH SHARED PROGRAMS AND ACTIVITIES. MEMBER REPRESENTATIVES ADVOCATE FOR AASLD'S MISSION AT GLOBAL MEETINGS, CREATING PROGRAMS THAT RESONATE WITH AUDIENCES INTERESTED IN MUTUAL TOPICS.4. PATIENT ENGAGEMENT: AASLD IS DEDICATED TO DEEPENING PATIENT CONNECTIONS BY INCREASING PATIENT REPRESENTATION IN ITS ACTIVITIES, ENHANCING ACCESS TO EXPERT RESOURCES, AND BUILDING ROBUST ADVOCACY PARTNERSHIPS TO AMPLIFY THE PATIENT VOICE IN HEPATOLOGY.CLINICAL AND PUBLIC POLICY: AASLD'S PUBLIC POLICY COMMITTEE LEADS A ROBUST ADVOCACY PROGRAM, HOSTING TWO KEY ANNUAL EVENTS: - LIVER CAPITOL HILL DAY: IN PARTNERSHIP WITH PATIENT ADVOCACY ORGANIZATIONS, AASLD EDUCATES CONGRESSIONAL LEGISLATORS AND STAFF ON CRITICAL ISSUES IN LIVER DISEASE RESEARCH AND PATIENT CARE, DRIVING POLICY CHANGE.- FEDERAL AGENCY DAY: AASLD ENGAGES WITH FEDERAL AGENCY PARTNERS TO ALIGN THE SCIENTIFIC COMMUNITY WITH FEDERAL RESEARCH PRIORITIES, FOSTERING COLLABORATION AND INNOVATION.AASLD ENSURES ITS MEMBERS STAY INFORMED ON LEGISLATIVE AND AGENCY DECISIONS IMPACTING HEPATOLOGY, ENCOURAGING ACTIVE PARTICIPATION IN PUBLIC POLICY ADVOCACY.

  Expenses $5,929,583 · Grants $1,208,397 · Revenue $1,279,000

• MEMBERSHIP & MENTORSHIP: AASLD'S VIBRANT MEMBERSHIP OF OVER 7,000 PROFESSIONALSSPANNING PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, STUDENTS, AND ALLIED HEALTH EXPERTSDRIVES HEPATOBILIARY RESEARCH AND PATIENT CARE WORLDWIDE. THE AASLD MENTORSHIP PROGRAM INSPIRES AND NURTURES THE NEXT GENERATION OF HEPATOLOGISTS BY PAIRING MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS, AND EARLY-CAREER PROFESSIONALS WITH SEASONED MENTORS. THIS PROGRAM ENSURES A LEGACY OF SKILLED, KNOWLEDGEABLE HEPATOLOGISTS DEDICATED TO ACADEMIC MEDICINE AND PATIENT CARE.WEBSITE: AASLD'S WEBSITES (WWW.AASLD.ORG AND HCVGUIDELINES.ORG) SERVE AS A VITAL HUB FOR MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND THE PUBLIC, OFFERING SEAMLESS ACCESS TO CUTTING-EDGE HEPATOLOGY RESOURCES. WITH OVER 2.1 MILLION ANNUAL VISITORS, THE SITE FACILITATES EXPLORATION OF RESEARCH, EDUCATIONAL OFFERINGS, AND PROFESSIONAL OPPORTUNITIES IN HEPATOLOGY.COMMUNICATIONSAASLD KEEPS ITS COMMUNITY INFORMED THROUGH THE BIWEEKLY AASLD E-NEWS, DELIVERING UPDATES ON RESEARCH, MILESTONES, AND POLICY DEVELOPMENTS TO MEMBERS. THE ASSOCIATION ALSO AMPLIFIES ITS IMPACT THROUGH STRATEGIC MEDIA RELATIONS, SPOTLIGHTING GROUNDBREAKING RESEARCH FROM THE LIVER MEETING AND ADVOCATING FOR ADVANCES IN LIVER DISEASE TREATMENT AND PATIENT CARE.

  Expenses $2,141,064 · Grants $110,000 · Revenue $1,916,505

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  $1,208,397

  INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• AASLD FOUNDATION

  501(C)(3) · INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND PEOPLE WHO STUDY LIVER DISEASE · VA · controlled entity

  Directly controlled by AASLD

Provenance

Return type

form_990

Tax year

2024

Filed

17 March 2026

IRS schema version

2024v5.5

Source object

202630769349301218

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.